AbbVie ends 11-year Calico partnership focused on aging research
FierceBiotech - 12-Nov-2025AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
Join the club for FREE to access the whole archive and other member benefits.
Information on extending life expectancy to allow technologies to catch up and stop and reverse aging for good. Focussing on new technologies and treatments aimed at radical life extension, rather than the improvements in treatments of diseases covered in the health section.
Particularly interested in increased health span rather than lifespan.
Keep an eye on fountains of youth - contenders for radical reduction or reversal of aging.
Read more about: Ageing Research, Anti-Aging, Biological Age, Calorie Restriction, Cryonics, Ethics, Fountains of Youth, Gene Therapy, Immortal Animals, Life Expectancy, Longevity Industry Investments, Mitochondria, Regenerative Medicine, Rejuvenation, Senescent Cells, Stem Cells, Telomeres, Young Blood.
AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
Insilico’s AI cut drug discovery to 18 months, spurring Lilly’s investment
Graphene-based BCIs use Azure AI to adapt in real time for Parkinson’s and stroke therapy
CRISPR therapy cut LDL and triglycerides by roughly 50% after a single infusion
Click on resource name for more details.
Why Government Must Unlock Biotech's Potential to Maximize Longevity, written by Breanna Deutch
Levity Podcast Episode-Felix Werth’s Campaign to Defeat Death
Optispan podcast episode - Brad Stanfield discusses his journey from GP to longevity leader
Longevity Roadmap Podcast- Jennifer Elisseeff explores advances in tissue engineering and regenerative medicine
26-Jun-2026
The global event empowering everyone to live longer, better – now (London, UK)
InsideTracker Podcast Episode - Peter Fedichev on why resilience, not disease treatment, is the key to longevity
Comparison of a senotherapeutic peptide with an everyday moisturiser
Will Jeanne Calment’s record 122 years ever be broken?
Has this century seen extraordinarily long-lived Wimbledon champions, or are winners over 30 years of age the new normal?